Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Pernix Therapeutics Holdings Inc.

Headquarters: Morristown, NJ, United States of America
Website: N/A
Year Founded: 1996
Status: Acquired

BioCentury | Jun 27, 2020
Regulation

Boxed warning on Zogenix’s Dravet syndrome therapy could hamper market prospects

Agency rebuffs wet AMD therapy from AbbVie, Molecular Partners, approves Chiasma’s oral acromegaly drug
BioCentury | Apr 27, 2018
Company News

Orexigen accepts $75M stalking horse bid

BioCentury | Oct 18, 2017
Company News

Management tracks: Gilead, Ipsen, Depomed

BioCentury | Aug 15, 2016
Company News

Pernix Therapeutics neurology news

BioCentury | Mar 14, 2016
Analyst Picks & Changes

Analyst picks & changes

BioCentury | Oct 12, 2015
Clinical News

Pernix Therapeutics preclinical data

BioCentury | Jun 8, 2015
Company News

Zogenix, Pernix Therapeutics deal

BioCentury | May 25, 2015
Clinical News

Treximet sumatriptan/naproxen regulatory update

Items per page:
1 - 10 of 64
Help Center
Username
Request a Demo
Request Training
Ask a Question